Keyphrases
Pulmonary Hypertension
40%
Pulmonary Artery Smooth muscle Cells (PASMCs)
40%
Pulmonary Arterial Hypertension
32%
Pulmonary Artery
25%
Voltage Dependence
21%
Ca2+ Channels
21%
Reactive Oxygen Species
18%
Chronic Hypoxia
18%
Pathogenic Role
18%
Ca2+
16%
Hypoxia-induced Pulmonary Hypertension
13%
Cytosolic Free Ca2+
11%
Ca2+ Concentration
11%
Platelet-derived Growth Factor Receptor (PDGFR)
10%
Pulmonary Microvascular Endothelial Cells (PMVECs)
9%
Cx40
9%
Theater Arts
9%
Functional Characterization
9%
Lighting Controller
9%
Pulmonary Vasodilators
9%
Endothelium-dependent
9%
Documentary Editing
9%
Cav1.2
9%
Smooth muscle
9%
Pulmonary Artery Smooth muscle Cell Proliferation
9%
CALHM1
9%
Neoliberal Theory
9%
Stromal Interaction Molecule 1 (STIM1)
9%
Divergent Effects
9%
Family Brand
9%
TH Receptor
9%
Mammalian Target of Rapamycin (mTOR)
9%
Calcium-sensing Receptor (CaSR)
9%
Classical Hollywood
9%
STIM2
9%
Vascular Tension
9%
Platelet-derived Growth factor-BB (PDGF-BB)
9%
Human Antigen R
9%
Disease Severity
9%
Sodium-glucose Cotransporter Inhibitors
9%
Right Ventricular Remodeling
9%
TRP Channels
9%
Transcriptome Profile
9%
Independent Distribution
9%
Chloroquine
9%
Global Television
9%
L-type
9%
T-type
9%
Women's Television
9%
Army Wives
9%
Imperial Gaze
9%
MTOR Complex 2 (mTORC2)
9%
Americans Abroad
9%
Novel Candidate Genes
9%
Voltage-gated Ca2+ Channels
9%
Orai2
9%
Cav3.2
9%
Coronary Microvascular Disease
9%
TALLYHO
9%
Protein O-GlcNAcylation
9%
Oxygen Redox
9%
Excess Protein
9%
Practical Course
9%
Idiopathic Pulmonary Arterial Hypertension
8%
Endothelium-derived Hyperpolarizing Factor
7%
Pulmonary Vasoconstriction
7%
Mesenteric Artery
7%
Smooth muscle Cells
6%
Editing Process
6%
O-GlcNAcase
5%
Medicine and Dentistry
Pulmonary Hypertension
65%
Smooth Muscle Cell
31%
Vascular Remodeling
30%
Calcium Ion
29%
Arterial Smooth Muscle Cell
29%
Diabetes Mellitus
27%
Lung Vasoconstriction
20%
Hypoxia
20%
Pulmonary Artery
20%
Ion Channel
18%
Endothelial Cell
17%
Pulmonary Artery Smooth Muscle Cell
15%
Endothelial Function
11%
Platelet Derived Growth Factor Receptor
11%
Lung Vascular Resistance
10%
Calcium Channel
10%
Blood Vessel Tone
10%
Cell Proliferation
9%
Hypoxia-Induced Pulmonary Hypertension
9%
Coronary Artery Dilatation
9%
Stromal Interaction Molecule 2
9%
Cav1.2
9%
Smooth Muscle
9%
Afterload
9%
Reactive Oxygen Species
9%
Thyroid Hormone Receptor
9%
Thyroid Hormone
9%
Coronary Microvascular Dysfunction
9%
Sodium Glucose Cotransporter Inhibitor
9%
Calcium Sensing Receptor
9%
Platelet Derived Growth Factor
9%
Connexin 40
9%
Chloroquine
9%
Endoplasmic reticulum
9%
Cation Channel
9%
Coronary Artery
8%
Mechanistic Target of Rapamycin
7%
Hormone Therapy
7%
Pulmonary Vasculature
7%
Systolic Blood Pressure
6%
Protein Expression
5%
Potassium Channel
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Calcium Ion
75%
Mouse
56%
Hypoxia
41%
Calcium Channel
34%
Vascular Remodeling
33%
Hypoxia-Induced Pulmonary Hypertension
29%
Protein P53
18%
Chloroquine
18%
Calcium Sensing Receptor
18%
Channel Blocker
11%
Dihydropyridine
11%
Microangiopathy
10%
Stromal Interaction Molecule 2
9%
Reactive Oxygen Metabolite
9%
Peripheral Vasodilating Agent
9%
Ion Channel
9%
Non Insulin Dependent Diabetes Mellitus
9%
Hypoxic Lung Vasoconstriction
9%
Diabetes Mellitus
9%
Sodium Glucose Cotransporter Inhibitor
9%
Cation Channel
9%
Connexin 40
9%
Potassium Ion
8%
Mammalian Target of Rapamycin
7%
Canagliflozin
7%
Receptor
7%
Nifedipine
7%